Inhibrx Biosciences, Inc. (INBX)

Inhibrx Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022
Period Ending	Dec 20, 2024	Dec 31, 2023	Dec 31, 2022
Debt / Equity Ratio	0.01	-0.40	-0.69
Asset Turnover	-	0.08	-
Inventory Turnover	-	24.95	-
Quick Ratio	4.48	0.02	0.01
Current Ratio	4.70	0.41	0.30
Return on Assets (ROA)	-	-447.73%	-

Source: S&P Capital IQ. Standard template. Financial Sources.